These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28671958)

  • 1. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
    Ploug T; Holm S
    PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
    Smith LA; Douglas J; Braxton AA; Kramer K
    J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
    Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
    Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    May T
    J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
    Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
    Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
    [No Abstract]   [Full Text] [Related]  

  • 10. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.
    Yu JH; Harrell TM; Jamal SM; Tabor HK; Bamshad MJ
    Am J Hum Genet; 2014 Jul; 95(1):77-84. PubMed ID: 24975944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
    Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
    J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings.
    Strong KA; Zusevics KL; Bick DP; Veith R
    WMJ; 2014 Oct; 113(5):179-84. PubMed ID: 25739160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
    Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for returning genomic incidental findings? We need to talk!
    Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R
    Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory policies on reporting secondary findings in clinical whole exome sequencing: initial uptake of the ACMG's recommendations.
    Hufnagel SB; Antommaria AH
    Am J Med Genet A; 2014 May; 164A(5):1328-31. PubMed ID: 24458369
    [No Abstract]   [Full Text] [Related]  

  • 17. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.
    Kaphingst KA; Ivanovich J; Biesecker BB; Dresser R; Seo J; Dressler LG; Goodfellow PJ; Goodman MS
    Clin Genet; 2016 Mar; 89(3):378-84. PubMed ID: 25871653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional Findings in Three Patients Affected by Glycogen Storage Disease Type VI and Fanconi-Bickel Syndrome.
    Eghbali M; Fatemi KS; Salehpour S; Abiri M; Saei H; Talebi S; Olyaei NA; Yassaee VR; Modarressi MH
    Front Genet; 2020; 11():601566. PubMed ID: 33505429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Views of primary care providers regarding the return of genome sequencing incidental findings.
    Strong KA; Zusevics KL; Bick D; Veith R
    Clin Genet; 2014 Nov; 86(5):461-8. PubMed ID: 24673592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood.
    Hufnagel SB; Martin LJ; Cassedy A; Hopkin RJ; Antommaria AH
    Am J Med Genet A; 2016 Aug; 170(8):2083-8. PubMed ID: 27149544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.